Peter D. O'Hanley
2008
In 2008, Peter D. O'Hanley earned a total compensation of $538K as SVP of Clinical Development and Regulatory Affairs at Sarepta Therapeutics, a 13% decrease compared to previous year.
Compensation breakdown
| Option Awards | $259,287 |
|---|---|
| Salary | $269,533 |
| Other | $9,200 |
| Total | $538,020 |
O'Hanley received $269.5K in salary, accounting for 50% of the total pay in 2008.
O'Hanley also received $259.3K in option awards and $9.2K in other compensation.
Rankings
In 2008, Peter D. O'Hanley's compensation ranked 6,289th out of 9,135 executives tracked by ExecPay. In other words, O'Hanley earned more than 31.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,289 out of 9,135 | 31st |
Division Manufacturing | 2,324 out of 3,436 | 32nd |
Major group Chemicals And Allied Products | 508 out of 815 | 38th |
Industry group Drugs | 343 out of 597 | 43rd |
Industry Pharmaceutical Preparations | 255 out of 408 | 38th |
Source: SEC filing on April 14, 2009.
O'Hanley's colleagues
We found seven more compensation records of executives who worked with Peter D. O'Hanley at Sarepta Therapeutics in 2008.
2008
Leslie Hudson
Sarepta Therapeutics
Chief Executive Officer
2008
Alan Timmins
Sarepta Therapeutics
Chief Operating Officer
2008
J Boyle
Sarepta Therapeutics
Chief Financial Officer
2008
Dwight Weller
Sarepta Therapeutics
Senior Vice President of Chemistry and Manufacturing
2008
Mark Webber
Sarepta Therapeutics
Chief Financial Officer
2008
Patrick Iversen
Sarepta Therapeutics
Senior Vice President of Strategic Alliances
2008
K Forrest
Sarepta Therapeutics